703 related articles for article (PubMed ID: 32879009)
1. Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes.
Fu C; Peng P; Loschko J; Feng L; Pham P; Cui W; Lee KP; Krug AB; Jiang A
Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23730-23741. PubMed ID: 32879009
[TBL] [Abstract][Full Text] [Related]
2. DC-Based Vaccines for Cancer Immunotherapy.
Fu C; Zhou L; Mi QS; Jiang A
Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33255895
[TBL] [Abstract][Full Text] [Related]
3. Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells.
Nierkens S; den Brok MH; Garcia Z; Togher S; Wagenaars J; Wassink M; Boon L; Ruers TJ; Figdor CG; Schoenberger SP; Adema GJ; Janssen EM
Cancer Res; 2011 Oct; 71(20):6428-37. PubMed ID: 21788345
[TBL] [Abstract][Full Text] [Related]
4. Plasmacytoid Dendritic Cells and Cancer Immunotherapy.
Fu C; Zhou L; Mi QS; Jiang A
Cells; 2022 Jan; 11(2):. PubMed ID: 35053338
[TBL] [Abstract][Full Text] [Related]
5. Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells.
Sapoznikov A; Fischer JA; Zaft T; Krauthgamer R; Dzionek A; Jung S
J Exp Med; 2007 Aug; 204(8):1923-33. PubMed ID: 17646404
[TBL] [Abstract][Full Text] [Related]
6. Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells.
Koyama M; Hashimoto D; Aoyama K; Matsuoka K; Karube K; Niiro H; Harada M; Tanimoto M; Akashi K; Teshima T
Blood; 2009 Feb; 113(9):2088-95. PubMed ID: 19144988
[TBL] [Abstract][Full Text] [Related]
7. Facilitated antigen uptake and timed exposure to TLR ligands dictate the antigen-presenting potential of plasmacytoid DCs.
Kool M; Geurtsvankessel C; Muskens F; Madeira FB; van Nimwegen M; Kuipers H; Thielemans K; Hoogsteden HC; Hammad H; Lambrecht BN
J Leukoc Biol; 2011 Dec; 90(6):1177-90. PubMed ID: 21934071
[TBL] [Abstract][Full Text] [Related]
8. Analysis of DC Functions Using CD205-DTR Knock-In Mice.
Fukaya T; Takagi H; Uto T; Arimura K; Sato K
Methods Mol Biol; 2016; 1423():291-308. PubMed ID: 27142025
[TBL] [Abstract][Full Text] [Related]
9. Type I IFN Sensing by cDCs and CD4
Shirley JL; Keeler GD; Sherman A; Zolotukhin I; Markusic DM; Hoffman BE; Morel LM; Wallet MA; Terhorst C; Herzog RW
Mol Ther; 2020 Mar; 28(3):758-770. PubMed ID: 31780366
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial reactive oxygen species regulate the induction of CD8
Oberkampf M; Guillerey C; Mouriès J; Rosenbaum P; Fayolle C; Bobard A; Savina A; Ogier-Denis E; Enninga J; Amigorena S; Leclerc C; Dadaglio G
Nat Commun; 2018 Jun; 9(1):2241. PubMed ID: 29884826
[TBL] [Abstract][Full Text] [Related]
11. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells.
Bachem A; Güttler S; Hartung E; Ebstein F; Schaefer M; Tannert A; Salama A; Movassaghi K; Opitz C; Mages HW; Henn V; Kloetzel PM; Gurka S; Kroczek RA
J Exp Med; 2010 Jun; 207(6):1273-81. PubMed ID: 20479115
[TBL] [Abstract][Full Text] [Related]
12. Conventional but not plasmacytoid dendritic cells foster the systemic virus-induced type I IFN response needed for efficient CD8 T cell priming.
Hervas-Stubbs S; Riezu-Boj JI; Mancheño U; Rueda P; Lopez L; Alignani D; Rodríguez-García E; Thieblemont N; Leclerc C
J Immunol; 2014 Aug; 193(3):1151-61. PubMed ID: 24973449
[TBL] [Abstract][Full Text] [Related]
13. β-catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8⁺ T cells.
Liang X; Fu C; Cui W; Ober-Blöbaum JL; Zahner SP; Shrikant PA; Clausen BE; Flavell RA; Mellman I; Jiang A
J Leukoc Biol; 2014 Jan; 95(1):179-90. PubMed ID: 24023259
[TBL] [Abstract][Full Text] [Related]
14. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
[TBL] [Abstract][Full Text] [Related]
15. Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation.
Mouriès J; Moron G; Schlecht G; Escriou N; Dadaglio G; Leclerc C
Blood; 2008 Nov; 112(9):3713-22. PubMed ID: 18698004
[TBL] [Abstract][Full Text] [Related]
16. CpG-A stimulates Hsp72 secretion from plasmacytoid dendritic cells, facilitating cross-presentation.
Tanaka T; Kajiwara T; Kutomi G; Kurotaki T; Saito K; Kanaseki T; Tsukahara T; Hirohashi Y; Torigoe T; Hirata K; Okamoto Y; Sato N; Tamura Y
Immunol Lett; 2015 Sep; 167(1):34-40. PubMed ID: 26141624
[TBL] [Abstract][Full Text] [Related]
17. Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.
Wei J; Waithman J; Lata R; Mifsud NA; Cebon J; Kay T; Smyth MJ; Sadler AJ; Chen W
J Immunol; 2010 Nov; 185(10):6013-22. PubMed ID: 20956347
[TBL] [Abstract][Full Text] [Related]
18. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability.
Periasamy P; O'Neill HC
Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375
[TBL] [Abstract][Full Text] [Related]
19. Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment.
Fu C; Jiang A
Front Immunol; 2018; 9():3059. PubMed ID: 30619378
[TBL] [Abstract][Full Text] [Related]
20. Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.
Tel J; Schreibelt G; Sittig SP; Mathan TS; Buschow SI; Cruz LJ; Lambeck AJ; Figdor CG; de Vries IJ
Blood; 2013 Jan; 121(3):459-67. PubMed ID: 23212525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
